ABERNETHY MATT (CIK 1724097) reported 19 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-05). Recent activity: Sell NBIX (2,249 shares), Buy NBIX (2,133 shares), Sell NBIX (1,151 shares), Buy NBIX (2,241 shares), Sell NBIX (1,210 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-05 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | Sell | 2,249 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | Buy | 2,133 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | Sell | 1,151 | $141,688 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | Buy | 2,241 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | Sell | 1,210 | $150,185 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | Buy | 2,566 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | Sell | 1,385 | $171,906 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | Buy | 9,968 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | Sell | 5,378 | $667,517 |
| 2026-02-03 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | Buy | 2,437 | $0 |
| 2026-02-03 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | Sell | 1,368 | $186,130 |
| 2025-02-14 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | Buy | 2,566 | $0 |
| 2025-02-14 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | Sell | 1,352 | $157,981 |
| 2025-02-14 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | Buy | 2,241 | $0 |
| 2025-02-14 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | Sell | 1,206 | $140,945 |
| 2025-02-12 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | Buy | 1,860 | $0 |
| 2025-02-12 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | Sell | 980 | $115,905 |
| 2025-02-04 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | Buy | 2,436 | $0 |
| 2025-02-04 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | Sell | 1,283 | $196,132 |
Source: SEC Form 4 filings · as of 2026-03-05